Drug Type Small molecule drug |
Synonyms PWT 33597, PWT-33597, PWT33597 mesylate |
Target |
Mechanism PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors), mTOR inhibitors(Serine/threonine-protein kinase mTOR inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H34F2N8O7S2 |
InChIKeyXSLUGEGXPCDRTN-UHFFFAOYSA-N |
CAS Registry1246203-36-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 1 | US | 01 Jun 2011 | |
Solid tumor | Phase 1 | US | - |